Carpenter LL - Search Results

1

Tryptophan depletion during continuous CSF sampling in healthy human subjects.

Carpenter LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PD, Price LH, Heninger GR, McDougle CJ. Carpenter LL, et al. Neuropsychopharmacology. 1998 Jul;19(1):26-35. doi: 10.1016/S0893-133X(97)00198-X. Neuropsychopharmacology. 1998. PMID: 9608574

2

A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Carpenter LL, McDougle CJ, Epperson CN, Price LH. Carpenter LL, et al. Drug Saf. 1996 Aug;15(2):116-34. doi: 10.2165/00002018-199615020-00004. Drug Saf. 1996. PMID: 8884163 Review.

3

[123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts.

Malison RT, McCance E, Carpenter LL, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB. Malison RT, et al. Among authors: carpenter ll. Psychopharmacology (Berl). 1998 Jun;137(4):321-5. doi: 10.1007/s002130050625. Psychopharmacology (Berl). 1998. PMID: 9676890 Clinical Trial.

4

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.

Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS. Malison RT, et al. Biol Psychiatry. 1998 Dec 1;44(11):1090-8. doi: 10.1016/s0006-3223(98)00272-8. Biol Psychiatry. 1998. PMID: 9836013 Free article. Clinical Trial.

5

Mirtazapine augmentation in the treatment of refractory depression.

Carpenter LL, Jocic Z, Hall JM, Rasmussen SA, Price LH. Carpenter LL, et al. J Clin Psychiatry. 1999 Jan;60(1):45-9. doi: 10.4088/jcp.v60n0110. J Clin Psychiatry. 1999. PMID: 10074878 Clinical Trial.

6

Clinical experience with mirtazapine in the treatment of panic disorder.

Carpenter LL, Leon Z, Yasmin S, Price LH. Carpenter LL, et al. Ann Clin Psychiatry. 1999 Jun;11(2):81-6. doi: 10.1023/a:1022394415585. Ann Clin Psychiatry. 1999. PMID: 10440525 Clinical Trial.

7

Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder.

Longhurst JG, Carpenter LL, Epperson CN, Price LH, McDougle CJ. Longhurst JG, et al. Among authors: carpenter ll. Biol Psychiatry. 1999 Aug 15;46(4):573-6. doi: 10.1016/s0006-3223(99)00019-0. Biol Psychiatry. 1999. PMID: 10459409 Clinical Trial.

8

Limited efficacy of ketoconazole in treatment-refractory major depression.

Malison RT, Anand A, Pelton GH, Kirwin P, Carpenter L, McDougle CJ, Heninger GR, Price LH. Malison RT, et al. J Clin Psychopharmacol. 1999 Oct;19(5):466-70. doi: 10.1097/00004714-199910000-00011. J Clin Psychopharmacol. 1999. PMID: 10505589 Clinical Trial.

9

Psychotic depression: what is it and how should we treat it?

Carpenter LL, Price LH. Carpenter LL, et al. Harv Rev Psychiatry. 2000 May-Jun;8(1):40-2. Harv Rev Psychiatry. 2000. PMID: 10824297 No abstract available.

10

Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.

Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS. Vythilingam M, et al. Among authors: carpenter ll. J Clin Endocrinol Metab. 2000 Nov;85(11):4138-45. doi: 10.1210/jcem.85.11.6968. J Clin Endocrinol Metab. 2000. PMID: 11095445 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters